[1] |
CAO Shan, PANG Bo, XU Yingli, ZHANG Jingsheng, CHEN Mengping, ZHANG Yu, WANG Yaxin, BAO Lei, GENG Zihan, GUO Shanshan, ZHAO Ronghua, CUI Xiaolan.
Effects of Shufeng Jiedu capsules prophylactic administration on TLR4-mediated inflammatory injury in lung tissue in a mouse model of inffuenza virus infeciton
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 45-50.
|
[2] |
LIU Qian, HU Jing, LI Bo, YANG Xiaojing.
Jinghuaweikang capsules combined with quadruple therapy in the treatment of Helicobacter pylori associated gastritis: a systematic evaluation and meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1039-1045.
|
[3] |
ZHU Chunwu, YU Xuejun, SUN Xin, LIU Chenghai.
Overview of hepatotoxicity of Xianling Gubao capsules
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 496-499.
|
[4] |
SU Xinxin, LYU Jian, XIE Yanming.
Efficacy and safety of Toutongning capsules in the treatment of chronic headache: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 433-440.
|
[5] |
CHEN Mengping, WANG Yaxin, YAO Rongmei, BAO Lei, ZHAO Ronghua, SUN Jing, GENG Zihan, BAO Yanyan, DAI Min, GUO Shanshan, CUI Xiaolan.
Mechanisms of Qingkailing soft capsules against coronavirus pneumonia based on network pharmacology and experimental verification
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 253-257.
|
[6] |
DU Ying, XIE Yanming, WANG Lianxin, GENG Hongjiao, LI Xiangjie.
Clinical characteristics and drug combination analysis of Lianhua Qingwen capsules (granules) in the real world
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 296-300.
|
[7] |
LI Xiaojuan, ZHANG Aiwu, WEI Ying.
Analysis of one case of acute drug-induced liver injury caused by Shangfengting capsules
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 213-214.
|
[8] |
HAO Xiaohui, ZHANG Ping, WU Lulu, WANG Lihua.
Mining and analysis of ixazomib citrate capsules safety signals based on FAERS database
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1427-1431.
|
[9] |
SUN Jing, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, CUI Xiaolan.
Effects of Shufeng Jiedu capsules combined with levofloxacin in the treatment of mouse pneumonia infected by multidrug-resistant Pseudomonas aeruginosa
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 52-56.
|
[10] |
ZHAO Xiaoxiao, LIU Fumei, XI Junyu, SHI Buwen, XIE Yanming, WANG Lianxin.
Systematic evaluation and Meta-analysis of Danhuang Quyu capsules in the treatment of chronic pelvic inflammatory disease
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 1002-1008.
|
[11] |
ZHANG Jinlin, LI Yan, CHEN Tao, ZHOU Ying, SONG Yunfeng, JIA Huanhuan, YUAN Yaozuo, CAO Ling, ZHANG Mei, WANG Chen, XU Mingzhe.
Establishment of a bio-relevance dissolution method for lansoprazole enteric capsules
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 702-707.
|
[12] |
ZHANG Zhibin, YAO Rongmei, MA Huixia, BAO Jutai, GUO Shanshan, CUI Xiaolan.
Inhibitory effect of total saponins from Kangke capsules on apoptosis induced by Coxsackie virus B
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 384-389.
|
[13] |
ZHANG Lidan, XIE Yanming, SUN Menghua.
Therapeutic effects of Lianhua Qingwen capsules(granules) against pulmonary infections based on data mining in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 126-129.
|
[14] |
WANG Xin, ZHANG Jie, ZHANG Ming, ZHANG Nan, AI Chao.
One case of erythema multiforme drug eruption induced by acetylcysteine capsule combined with fudosteine tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 217-218.
|
[15] |
SUN Linxi, XIE Yanming, LI Yuanyuan, SUN Menghua, LI Xiangjie.
Ways 2247 elderly patients use Lianhua Qingwen capsules in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 32-35.
|